🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: To compare loss of ovarian parenchyma following ovarian endometr...
Status
Unknown
Location
University Hospital
Start Date
2010-11
Trial ID
NCT01596985
Treatments Being Tested
This first-in-human (FIH) phase 1 study is designed to evaluate in containe...
Status
Completed
Location
university of Antwerp - centre for the evaluation of vaccination
Start Date
2017-05-16
Trial ID
NCT03430349
Treatments Being Tested
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested
The purpose of the study is to evaluate the safety and immunogenicity of a ...
Status
Not Yet Recruiting
Location
Uniformed Services University of the Health Sciences
Start Date
2025-08-15
Trial ID
NCT07088822
Treatments Being Tested
The purpose of this ex-vivo study is to estimate the optimal platelet quant...
Status
Completed
Location
University Hospital of Geneva
Start Date
2011-09
Trial ID
NCT01839968
Treatments Being Tested
This study is a phase II, multi-centre, open label study in patients with a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-07-29
Trial ID
NCT03933761
Treatments Being Tested
The TELE FRAIL clinical trial is a randomized trial designed to compare, am...
Status
Not Yet Recruiting
Location
Calle de Nuestra Señora de Guadalupe, Nº 5 y 7 28028, Madrid (España)
Start Date
2025-01
Trial ID
NCT06742970
Treatments Being Tested
Bleeding under vitamin K antagonists are a major iatrogenic causes of hospi...
Status
Unknown
Location
CHU Clermont-Ferrand
Start Date
2012-08
Trial ID
NCT01742871
This multicenter, randomized, double-blind, placebo-controlled trial aims t...
Status
Not Yet Recruiting
Location
Quanzhou First Hospital, Fujian
Start Date
2026-04-18
Trial ID
NCT07558525
Treatments Being Tested
Microvascular inflammation, the hallmark histological criteria of antibody-...
Status
Completed
Location
Hôpital Pellegrin
Start Date
2021-11-08
Trial ID
NCT04851145
Treatments Being Tested